VCYT beat EPS expectations by 94.33%
Feb 24, 2025, 11:33 PM
0.00%
What does VCYT do
Veracyte, headquartered in South San Francisco, develops diagnostic products for various cancers and employs 815 people. The company went public in 2013 and offers tests like Afirma and Decipher.
Veracyte (VCYT) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Veracyte's actual EPS was $0.06, beating the estimate of $0.12 per share, resulting in a 94.33% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.